BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11586295)

  • 1. A role for MLH3 in hereditary nonpolyposis colorectal cancer.
    Wu Y; Berends MJ; Sijmons RH; Mensink RG; Verlind E; Kooi KA; van der Sluis T; Kempinga C; van dDer Zee AG; Hollema H; Buys CH; Kleibeuker JH; Hofstra RM
    Nat Genet; 2001 Oct; 29(2):137-8. PubMed ID: 11586295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first functional study of MLH3 mutations found in cancer patients.
    Korhonen MK; Vuorenmaa E; Nyström M
    Genes Chromosomes Cancer; 2008 Sep; 47(9):803-9. PubMed ID: 18521850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability.
    Lipkin SM; Wang V; Jacoby R; Banerjee-Basu S; Baxevanis AD; Lynch HT; Elliott RM; Collins FS
    Nat Genet; 2000 Jan; 24(1):27-35. PubMed ID: 10615123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Germline mutation analysis in hMLH 1 and hMSH 2 genes in hereditary nonpolyposis colorectal cancer and colorectal cancer patients with familial history].
    Wang Y; Friedl W; Propping P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Dec; 15(6):333-6. PubMed ID: 9845760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
    Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
    Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic features of International Collaborative Group-hereditary nonpolyposis colorectal cancer families and suspected hereditary nonpolyposis colorectal cancer families.
    Yuan Y; Ye J; Zheng S;
    Chin Med J (Engl); 2004 May; 117(5):748-52. PubMed ID: 15161546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between two MLH3 variants (S845G and P844L)and colorectal cancer risk.
    de Jong MM; Hofstra RM; Kooi KA; Westra JL; Berends MJ; Wu Y; Hollema H; van der Sluis T; van der Graaf WT; de Vries EG; Schaapveld M; Sijmons RH; te Meerman GJ; Kleibeuker JH
    Cancer Genet Cytogenet; 2004 Jul; 152(1):70-1. PubMed ID: 15193445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
    Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
    Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
    Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms?
    Müller-Koch Y; Kopp R; Lohse P; Baretton G; Stoetzer A; Aust D; Daum J; Kerker B; Gross M; Dietmeier W; Holinski-Feder E
    Eur J Med Res; 2001 Nov; 6(11):473-82. PubMed ID: 11726306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Little evidence for involvement of MLH3 in colorectal cancer predisposition.
    Hienonen T; Laiho P; Salovaara R; Mecklin JP; Järvinen H; Sistonen P; Peltomäki P; Lehtonen R; Nupponen NN; Launonen V; Karhu A; Aaltonen LA
    Int J Cancer; 2003 Aug; 106(2):292-6. PubMed ID: 12800209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.
    Ou J; Rasmussen M; Westers H; Andersen SD; Jager PO; Kooi KA; Niessen RC; Eggen BJ; Nielsen FC; Kleibeuker JH; Sijmons RH; Rasmussen LJ; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):340-50. PubMed ID: 19156873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
    Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.